Related Experiment Video
Updated: Nov 25, 2025

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
Long non-coding RNA PLAC2 suppresses the survival of gastric cancer cells through down-regulating C-Myc
1Department of Gastrointestinal Surgery, Xinghua People's Hospital, The Affiliated Hospital of Yangzhou University, Taizhou, China. weixingg88@126.com.
Objective:
The aim of this study was to explore the effects of long non-coding ribonucleic acid (lncRNA) placenta-specific protein 2 (PLAC2) on the biological behaviors of gastric cancer (GC) cells by regulating the expression of c-Myc gene and its mechanism.
Patients And Methods:
The expression of PLAC2 in GC tissues and different GC cell lines was detected via quantitative Reverse Transcription-Polymerase Chain Reaction (qRT-PCR). The effects of PLAC2 on apoptosis and cycle, migration, and invasion of GC cells were detected using flow cytometry, wound healing assay, and transwell assay, respectively. After interference in PLAC2 expression, the changes in c-Myc expression were determined through qRT-PCR and Western blotting.
Results:
The expression level of PLAC2 was downregulated in 38 out of 45 cases of GC tissues compared with that in normal gastric tissues, and it also declined in GC cells. The results of flow cytometry showed that after overexpression of PLAC2, the cell cycle was arrested in the G1/G0 phase, and the apoptosis rate was increased. The results of wound healing assay and transwell assay revealed that both migration and invasion of GC cells were inhibited. After overexpression of PLAC2, the mRNA and protein expression levels of c-Myc declined.
Conclusions:
LncRNA PLAC2 affects the biological behaviors of GC cells by regulating the expression of c-Myc gene.
Insights
Long non-coding RNA PLAC2 (lncRNA PLAC2) suppresses gastric cancer cell progression by downregulating c-Myc. This study reveals lncRNA PLAC2 as a potential therapeutic target for gastric cancer.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Gastric cancer (GC) is a significant global health concern.
- Long non-coding RNAs (lncRNAs) play crucial roles in various cancers, including GC.
- The specific role of lncRNA placenta-specific protein 2 (PLAC2) in GC remains to be fully elucidated.
Purpose of the Study:
- To investigate the functional impact of lncRNA PLAC2 on the biological behaviors of gastric cancer cells.
- To explore the underlying mechanism involving the regulation of the c-Myc gene by lncRNA PLAC2.
Main Methods:
- Quantitative Reverse Transcription-Polymerase Chain Reaction (qRT-PCR) to assess PLAC2 expression in GC tissues and cell lines.
- Flow cytometry, wound healing, and Transwell assays to evaluate the effects of PLAC2 on GC cell apoptosis, cell cycle, migration, and invasion.
- Western blotting to determine c-Myc protein levels after PLAC2 manipulation.
Main Results:
- PLAC2 expression was significantly downregulated in GC tissues and cell lines.
- Overexpression of PLAC2 led to G1/G0 phase arrest and increased apoptosis in GC cells.
- Inhibition of GC cell migration and invasion was observed upon PLAC2 overexpression.
- Both mRNA and protein levels of c-Myc were reduced following PLAC2 overexpression.
Conclusions:
- LncRNA PLAC2 exerts tumor-suppressive effects on gastric cancer cells.
- The mechanism involves the downregulation of c-Myc expression.
- LncRNA PLAC2 represents a potential therapeutic target for gastric cancer treatment.
Related Concept Videos
Induced Pluripotent Stem Cells
Somatic...
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Abnormal Proliferation
MicroRNAs
MicroRNAs